Terms: = Liver cancer AND CEACAM5, CEA AND Clinical Outcome
11 results:
1. The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: A two-center cohort study.
Bai L; Lin ZY; Lu YX; Chen Q; Zhou H; Meng Q; Lin CP; Huang WL; Wan YL; Pan ZZ; Wang DS
Cancer Med; 2021 Nov; 10(22):8005-8019. PubMed ID: 34636145
[TBL] [Abstract] [Full Text] [Related]
2. Neo-adjuvant Chemotherapy-Induced Neutropenia Is Associated with Histological Responses and outcomes after the Resection of Colorectal liver Metastases.
Chen Q; Wu C; Zhao H; Wu J; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Zhou J; Cai J
J Gastrointest Surg; 2020 Mar; 24(3):659-670. PubMed ID: 30937711
[TBL] [Abstract] [Full Text] [Related]
3. cea change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastases.
Stremitzer S; Stift J; Graf A; Singh J; Starlinger P; Gruenberger B; Tamandl D; Gruenberger T
Ann Surg Oncol; 2015 Apr; 22(4):1315-23. PubMed ID: 25323471
[TBL] [Abstract] [Full Text] [Related]
4. Overexpressions of CK2β and XIAP are associated with poor prognosis of patients with cholangiocarcinoma.
Zhou F; Xu J; Ding G; Cao L
Pathol Oncol Res; 2014 Jan; 20(1):73-9. PubMed ID: 23828693
[TBL] [Abstract] [Full Text] [Related]
5. Regulatory T-cell-mediated inhibition of antitumor immune responses is associated with clinical outcome in patients with liver metastasis from colorectal cancer.
Brudvik KW; Henjum K; Aandahl EM; Bjørnbeth BA; Taskén K
Cancer Immunol Immunother; 2012 Jul; 61(7):1045-53. PubMed ID: 22159472
[TBL] [Abstract] [Full Text] [Related]
6. A gene signature distinguishing CD133hi from CD133- colorectal cancer cells: essential role for EGR1 and downstream factors.
Ernst A; Aigner M; Nakata S; Engel F; Schlotter M; Kloor M; Brand K; Schmitt S; Steinert G; Rahbari N; Koch M; Radlwimmer B; Weitz J; Lichter P
Pathology; 2011 Apr; 43(3):220-7. PubMed ID: 21436631
[TBL] [Abstract] [Full Text] [Related]
7. [Survival of patients with liver metastasis from colorectal cancer by different modes of therapy: a report of 363 cases].
Xu JM; Qin XY; Zhong YS; Wei Y; Fan J; Zhou J; Qin LX; Wang JH; Yan ZP; Cheng JM; Wu ZH
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):54-7. PubMed ID: 17575696
[TBL] [Abstract] [Full Text] [Related]
8. Re-evaluation of HER2 status in metastatic breast cancer and tumor-marker guided therapy with vinorelbine and trastuzumab.
Stemmler HJ; Stieber P; Lässig D; Heinemann V
Onkologie; 2005 Feb; 28(2):95-7. PubMed ID: 15692222
[TBL] [Abstract] [Full Text] [Related]
9. Gallbladder carcinomas: an immunoprognostic evaluation of P53, Bcl-2, cea and alpha-fetoprotein.
Kanthan R; Radhi JM; Kanthan SC
Can J Gastroenterol; 2000 Mar; 14(3):181-4. PubMed ID: 10758414
[TBL] [Abstract] [Full Text] [Related]
10. Surgical treatment of 32 patients with peripheral intrahepatic cholangiocarcinoma.
Harrison LE; Fong Y; Klimstra DS; Zee SY; Blumgart LH
Br J Surg; 1998 Aug; 85(8):1068-70. PubMed ID: 9717998
[TBL] [Abstract] [Full Text] [Related]
11. Metastatic potential of human colorectal carcinomas implanted into nude mice: prediction of clinical outcome in patients operated upon for cure.
Jessup JM; Giavazzi R; Campbell D; Cleary KR; Morikawa K; Hostetter R; Atkinson EN; Fidler IJ
Cancer Res; 1989 Dec; 49(24 Pt 1):6906-10. PubMed ID: 2582433
[TBL] [Abstract] [Full Text] [Related]
